Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

ATROPINE SULFATE

All products: general benefit

Other products in the same Health Canada class (S01FA) — coverage varies; not interchangeable

  • Cyclopentolate (Cyclogyl): not a benefit

Isopto Atropine · DIN 00035017 · 1% · Oph Sol

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Isopto Atropine · DIN 00035017 Manufacturer: Alcon Canada Inc.; listing date 1996-10-01 Health Canada: Marketed since 2023-09-11 · brand ALCON ATROPINE · ATC S01FA01 ATROPINE · form Solution · route Ophthalmic · ingredients ATROPINE SULFATE 1 %/W/V · company Alcon canada inc · schedule Prescription
Check this DIN again · Health Canada product record

Ministry pays: $0.5490 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=254 · Verify on the e-Formulary ↗ (DIN 00035017)

Source record
DIN 00035017: Isopto Atropine Raw flags: sec3=Y Item: 522400002; group id 605; item number 1566; lccId None; manufacturer id ALC Source form: Oph Sol; strength: 1% Recorded listing: General benefit Source prices (unrounded): $0.8900; ministry $0.5490 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00035017 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=254
Interchangeable products
Atropine · DIN 02023695 · $0.5490
Shortage status: resolved shortage (ended 2023-09-24); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00035017
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (52:24 Mydriatics) and how they are covered

Matched class: 52:24 Mydriatics

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. No displayed product is listed as a general benefit in this extract. Check its listing requirements below. 52:24 Mydriatics

CYCLOPENTOLATE HCL

· 2 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 1% · Oph Sol Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 52:24
Full class listing Related classes: 52:04 Anti-Infectives, 52:08 Anti-Inflammatory Agents, 52:16 Local Anesthetics, 52:20 Miotics, 52:32 Vasoconstrictors, 52:36 Other Eye, Ear, Nose and Throat Agents Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE ALCON ATROPINE (atropine sulfate ophthalmic solution, BP) is a cycloplegic and mydriatic agent indicated for uveitis and refraction. Geriatrics (> 65 years of age): Elderly patients may be at a higher risk for undiagnosed glaucoma as well as atropine-induced psychotic reactions and behavioural disturbances. Pediatrics (< 12 years of age): ALCON ATROPINE is contraindicated in pediatric patients <12 years of age because of the risk of serious systemic side effects. https://pdf.hres.ca/dpd_pm/00065579.PDF PM date: March 30, 2022 Source product: ALCON ATROPINE; DIN 00035017; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.